Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 2/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.37 |
| ▸ | ADH1C | P00326 | 1/20 | 0.37 |
| ▸ | ADH1A | P07327 | 1/20 | 0.37 |
| ▸ | ADH4 | P08319 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 4/20 | 0.35 |
| ▸ | DRD2 | P14416 | 4/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11807764 | 0.92 | ADH1C (0.47) | GNAI3GNAO1GNAI1ADH1CADH1A | |
| SCHEMBL10416391 | 0.89 | ADH1C (0.43) | ADH1CADH1AADH4DRD3DRD2 | |
| SCHEMBL3376484 | 0.89 | ADH1C (0.43) | ADH1CADH1AADH4DRD3DRD2 | |
| SCHEMBL29963181 | 0.88 | ADH1C (0.35) | GNAI3GNAO1GNAI1ADH1CADH1A | |
| SCHEMBL2693371 | 0.86 | DRD3 (0.43) | DRD3DRD2HTR1ADRD4 | |
| SCHEMBL1793781 | 0.86 | DRD3 (0.43) | DRD3DRD2HTR1ADRD4 | |
| SCHEMBL1793783 | 0.86 | DRD3 (0.43) | DRD3DRD2HTR1ADRD4 | |
| SCHEMBL3374356 | 0.84 | DRD3 (0.44) | ADH1CADH1AADH4DRD3DRD2 | |
| SCHEMBL5831335 | 0.80 | MEN1 (0.34) | KMT2A | |
| SCHEMBL14958732 | 0.80 | DRD2 (0.38) | DRD3DRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20250163281-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4484465-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| WO-2023163017-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | 株式会社ADEKA | 2023-08-31 | — | — | WO | disclosed |
| EP-3945102-B1 | ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF | ADEKA CORP (JP) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023281602-A1 | THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND PRODUCT | 三菱電機株式会社 | 2023-01-12 | — | — | WO | disclosed |
| US-20220177757-A1 | ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF | ADEKA CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
| EP-3945102-A1 | ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF | ADEKA CORPORATION (JP) | 2022-02-02 | — | — | EP | disclosed |
| EP-3196273-B1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | ADEKA CORP (JP) | 2021-06-30 | — | — | EP | disclosed |
| EP-3173454-B1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY | ADEKA CORP (JP) | 2021-05-05 | — | — | EP | disclosed |
| EP-3184598-A1 | ANTI-STATIC AGENT, ANTI-STATIC AGENT COMPOSITION, ANTI-STATIC RESIN COMPOSITION, AND MOLDING | Adeka Corporation (JP) | 2017-06-28 | — | — | EP | disclosed |
| EP-3173454-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY | Adeka Corporation (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-9580545-B2 | Antistatic agent, antistatic agent composition, antistatic resin composition, and molded article | ADEKA CORPORATION (JP) | 2017-02-28 | — | — | US | disclosed |
| US-20160289375-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | ADEKA CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| EP-2977424-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE | Adeka Corporation (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-20150353796-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY | ADEKA CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2949721-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY | Adeka Corporation (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-1022273-B1 | Pigment composition containing a pigment dispersing agent | TOYO INK MFG CO (JP) | 2004-07-14 | — | — | EP | disclosed |
| US-6123763-A | PROVIDES AN INK OR A COATING COMPOSITIONFREEDOM OF AGGREGATION, NON-CRYSTALLIZABILITY AND FLUIDITY, | TOYO INK MFG. CO., LTD. (JP) | 2000-09-26 | — | — | US | disclosed |
| EP-1022273-A1 | Pigment dispersing agent and pigment composition containing the same | TOYO INK MANUFACTURING CO., LTD. (JP) | 2000-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | GNAI3 4879/4885GNAO1 4587/4885GNAI1 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.